Our findings defining CHK1 as a ‘subverted’ tumor suppressor that stands in T-ALL as a major guardian of leukemia cell survival, thereby formally acting as an oncogene, reinforce a new way of viewing the mechanisms of cancer progression [2] and may set the ground for anti-leukemia breakthrough approaches. Here, CHEK1 is linked to cancer.